MedPath

Lundbeck Pharmaceuticals LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

FDA:7
CANADA:5

Drug Approvals

SABRIL

Approval Date
Sep 30, 2025
FDA

SABRIL

Approval Date
Sep 30, 2025
FDA

Vyepti

Approval Date
Mar 21, 2025
FDA

Onfi

Approval Date
Mar 12, 2024
FDA

CARNEXIV

Approval Date
Dec 1, 2021
FDA

Xenazine

Approval Date
Nov 1, 2019
FDA

Northera

Approval Date
Jul 1, 2019
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.